Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 202

1.

Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer.

Sjöberg E, Augsten M, Bergh J, Jirström K, Östman A.

Br J Cancer. 2016 Apr 26. doi: 10.1038/bjc.2016.104. [Epub ahead of print]

PMID:
27115465
2.

Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer.

Berntsson J, Nodin B, Eberhard J, Micke P, Jirström K.

Int J Cancer. 2016 Apr 13. doi: 10.1002/ijc.30138. [Epub ahead of print]

PMID:
27074317
3.

Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1, 2 and 3 in Periampullary Adenocarcinoma.

Elebro J, Heby M, Warfvinge CF, Nodin B, Eberhard J, Jirström K.

PLoS One. 2016 Apr 12;11(4):e0153533. doi: 10.1371/journal.pone.0153533. eCollection 2016.

4.

Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer.

Englund E, Bartoschek M, Reitsma B, Jacobsson L, Escudero-Esparza A, Orimo A, Leandersson K, Hagerling C, Aspberg A, Storm P, Okroj M, Mulder H, Jirström K, Pietras K, Blom AM.

Oncogene. 2016 Apr 11. doi: 10.1038/onc.2016.98. [Epub ahead of print]

PMID:
27065333
5.

A prospective evaluation of early detection biomarkers for ovarian cancer in the European EPIC cohort.

Terry KL, Schock H, Fortner RT, Hüsing A, Fichorova RN, Yamamoto HS, Vitonis AF, Johnson T, Overvad K, Tjønneland A, Boutron-Ruault MC, Mesrine S, Severi G, Dossus L, Rinaldi S, Boeing H, Benetou V, Lagiou P, Trichopoulou A, Krogh V, Kuhn E, Panico S, Bueno-de-Mesquita HB, Onland-Moret NC, Peeters PH, Gram IT, Weiderpass E, Duell EJ, Sanchez MJ, Ardanaz E, Etxezarreta N, Navarro C, Idahl A, Lundin E, Jirström K, Manjer J, Wareham NJ, Khaw KT, Smith Byrne K, Travis RC, Gunter MJ, Merritt MA, Riboli E, Cramer D, Kaaks R.

Clin Cancer Res. 2016 Apr 8. pii: clincanres.0316.2016. [Epub ahead of print]

PMID:
27060155
6.

Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer.

Lundgren S, Berntsson J, Nodin B, Micke P, Jirström K.

J Ovarian Res. 2016 Apr 6;9(1):21. doi: 10.1186/s13048-016-0232-0.

7.

The Impact of the Fourth Edition of the WHO Classification of Lung Tumours on Histological Classification of Resected Pulmonary NSCCs.

Micke P, Mattsson JS, Djureinovic D, Nodin B, Jirström K, Tran L, Jönsson P, Planck M, Botling J, Brunnström H.

J Thorac Oncol. 2016 Feb 9. pii: S1556-0864(16)00357-9. doi: 10.1016/j.jtho.2016.01.020. [Epub ahead of print]

PMID:
26872818
8.

Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma.

Hedner C, Borg D, Nodin B, Karnevi E, Jirström K, Eberhard J.

PLoS One. 2016 Feb 4;11(2):e0148101. doi: 10.1371/journal.pone.0148101. eCollection 2016.

9.

Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer.

Michaut M, Chin SF, Majewski I, Severson TM, Bismeijer T, de Koning L, Peeters JK, Schouten PC, Rueda OM, Bosma AJ, Tarrant F, Fan Y, He B, Xue Z, Mittempergher L, Kluin RJ, Heijmans J, Snel M, Pereira B, Schlicker A, Provenzano E, Ali HR, Gaber A, O'Hurley G, Lehn S, Muris JJ, Wesseling J, Kay E, Sammut SJ, Bardwell HA, Barbet AS, Bard F, Lecerf C, O'Connor DP, Vis DJ, Benes CH, McDermott U, Garnett MJ, Simon IM, Jirström K, Dubois T, Linn SC, Gallagher WM, Wessels LF, Caldas C, Bernards R.

Sci Rep. 2016 Jan 5;6:18517. doi: 10.1038/srep18517.

10.

The human complement inhibitor Sushi Domain-Containing Protein 4 (SUSD4) expression in tumor cells and infiltrating T cells is associated with better prognosis of breast cancer patients.

Englund E, Reitsma B, King BC, Escudero-Esparza A, Owen S, Orimo A, Okroj M, Anagnostaki L, Jiang WG, Jirström K, Blom AM.

BMC Cancer. 2015 Oct 19;15:737. doi: 10.1186/s12885-015-1734-7.

11.

S100A9 expressed in ER(-)PgR(-) breast cancers induces inflammatory cytokines and is associated with an impaired overall survival.

Bergenfelz C, Gaber A, Allaoui R, Mehmeti M, Jirström K, Leanderson T, Leandersson K.

Br J Cancer. 2015 Oct 20;113(8):1234-43. doi: 10.1038/bjc.2015.346. Epub 2015 Oct 8.

12.

Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma.

Tran L, Mattsson JS, Nodin B, Jönsson P, Planck M, Jirström K, Botling J, Micke P, Brunnström H.

Appl Immunohistochem Mol Morphol. 2015 Oct 1. [Epub ahead of print]

PMID:
26447895
13.

Downregulation of the cancer susceptibility protein WRAP53β in epithelial ovarian cancer leads to defective DNA repair and poor clinical outcome.

Hedström E, Pederiva C, Farnebo J, Nodin B, Jirström K, Brennan DJ, Farnebo M.

Cell Death Dis. 2015 Oct 1;6:e1892. doi: 10.1038/cddis.2015.250.

14.

Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer.

Mehmeti M, Allaoui R, Bergenfelz C, Saal LH, Ethier SP, Johansson ME, Jirström K, Leandersson K.

Breast Cancer Res. 2015 Sep 22;17:130. doi: 10.1186/s13058-015-0640-x.

15.

Prognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pancreatic cancer.

Elebro J, Ben Dror L, Heby M, Nodin B, Jirström K, Eberhard J.

Acta Oncol. 2016 Mar;55(3):286-96. doi: 10.3109/0284186X.2015.1075663. Epub 2015 Sep 11.

16.

Fibre intake and incident colorectal cancer depending on fibre source, sex, tumour location and Tumour, Node, Metastasis stage.

Vulcan A, Brändstedt J, Manjer J, Jirström K, Ohlsson B, Ericson U.

Br J Nutr. 2015 Sep 28;114(6):959-69. doi: 10.1017/S0007114515002743. Epub 2015 Aug 18.

PMID:
26281852
17.

Analysis of the Human Prostate-Specific Proteome Defined by Transcriptomics and Antibody-Based Profiling Identifies TMEM79 and ACOXL as Two Putative, Diagnostic Markers in Prostate Cancer.

O'Hurley G, Busch C, Fagerberg L, Hallström BM, Stadler C, Tolf A, Lundberg E, Schwenk JM, Jirström K, Bjartell A, Gallagher WM, Uhlén M, Pontén F.

PLoS One. 2015 Aug 3;10(8):e0133449. doi: 10.1371/journal.pone.0133449. eCollection 2015.

18.

Mutational and gene fusion analyses of primary large cell and large cell neuroendocrine lung cancer.

Karlsson A, Brunnström H, Lindquist KE, Jirström K, Jönsson M, Rosengren F, Reuterswärd C, Cirenajwis H, Borg Å, Jönsson P, Planck M, Jönsson G, Staaf J.

Oncotarget. 2015 Sep 8;6(26):22028-37.

19.

Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients.

Gustbée E, Tryggvadottir H, Markkula A, Simonsson M, Nodin B, Jirström K, Rose C, Ingvar C, Borgquist S, Jernström H.

BMC Clin Pathol. 2015 May 20;15:8. doi: 10.1186/s12907-015-0008-2. eCollection 2015.

20.

Delineating transcriptional networks of prognostic gene signatures refines treatment recommendations for lymph node-negative breast cancer patients.

Lanigan F, Brien GL, Fan Y, Madden SF, Jerman E, Maratha A, Aloraifi F, Hokamp K, Dunne EJ, Lohan AJ, Flanagan L, Garbe JC, Stampfer MR, Fridberg M, Jirstrom K, Quinn CM, Loftus B, Gallagher WM, Geraghty J, Bracken AP.

FEBS J. 2015 Sep;282(18):3455-73. doi: 10.1111/febs.13354. Epub 2015 Jul 14.

PMID:
26094870
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk